Mice subjected to TAC exhibited a high incidence of AF, frequent AF episodes, and prolonged mean AF duration, which could be effectively prevented by the delivery of siRNAs against EGR1, Gadd45b, or Runx1, as well as by transgenic expression of circNAB1 (Figure6a). The gene discussed is RUNX1; the disease is atrial fibrillation.